TP53 and cancer: These reactive intermediates can contribute to the initiation and/or progression of cancer by oxidative DNA damage and to cancer cell proliferation through the modulation of cell cycle proteins such as p53 or by suppressing cell death.32 These findings are consistent with well-established associations between chronic inflammation, oxidative stress and cancer.9,11